The "Technical Guidelines for Influenza Vaccination in China" was released, and these groups are recommended to be vaccinated first

The "China CDC News" public account released the "Technical Guidelines for Influenza Vaccination in China (2022-2023)" on August 25
.
At present, the severe epidemic situation of the global new crown pneumonia epidemic is still ongoing.
This summer, some provinces in southern China have experienced a peak of influenza epidemics in summer.
This winter and next spring, there may be the risk of superimposed epidemics of respiratory infectious diseases such as new crowns and influenza
.
Influenza is a vaccine-preventable disease.
In order to reduce the interference of influenza on the prevention and control of the new crown epidemic as much as possible, and to better guide the prevention and control of influenza in China and the application of vaccines, the China Center for Disease Control and Prevention organized relevant experts to compile and issue the "China Influenza Vaccine" in a timely manner.
Vaccination Technical Guidelines (2022-2023)
.
The guidelines mainly include the characteristics of influenza etiology, epidemiology, seasonality, etc.
, the health and economic burden caused by influenza in different populations, influenza vaccine types and immunogenicity, efficacy, efficacy, cost-benefit, safety, and 2022- 2023 vaccination recommendations
.
Based on the situation of the new crown pneumonia epidemic this year, the following key and high-risk groups are recommended to be vaccinated in a timely manner: medical personnel, including clinical treatment personnel, public health personnel, health quarantine personnel, etc.
; large-scale event participants and security personnel; elderly care institutions, long-term care institutions, Vulnerable people and employees in crowd gathering places such as welfare homes; people in key places, such as teachers and students in kindergartens, primary and secondary schools, detainees and staff in prison institutions, etc.
; other high-risk groups of influenza, including people aged 60 and above The elderly at home, children aged 6 months to 5 years , people with chronic diseases, family members and caregivers of infants
under 6 months old, and pregnant women .
Combined with the WHO position paper and its recommendations on the simultaneous vaccination of the new crown vaccine and influenza vaccine, as well as the preliminary results of the limited research on simultaneous vaccination published internationally and in my country, after careful consideration, it is believed that people aged 18 and over can When receiving immunization services once, inactivated influenza vaccine and new crown vaccine should be vaccinated on both limbs; for people under the age of 18, it is recommended that the interval between influenza vaccine and new crown vaccine is still greater than 14 days
.
Regarding the doses of vaccination, for inactivated influenza vaccines, children aged 6 months to 8 years old who are vaccinated for the first time should receive 2 doses of influenza vaccine with an interval of ≥4 weeks; those who have received 1 or more doses of influenza vaccine in 2021-2022 or before Children, 1 dose is recommended; children 9 years and older and adults only need 1 dose
.
For live attenuated influenza vaccine, only 1 dose is given, regardless of whether you have received a flu vaccine
.
This guideline is a synthesis of the latest research progress at home and abroad by the Influenza Vaccine Working Group of the National Immunization Program Technical Working Group of the Chinese Center for Disease Control and Prevention.
The updated and revised guidelines mainly include the following aspects: First, new research evidence has been added, especially the research results in China, including influenza disease burden, vaccine efficacy, vaccine safety monitoring, and vaccination.
Cost-effectiveness, etc.
; second, the relevant influenza prevention and control policies and measures issued by the state in the past year have been updated; third, the types of influenza vaccines that have been approved and released in China in 2022-2023 have been updated; fourth, the three Valence and quadrivalent influenza vaccine components; fifth, updated influenza vaccination recommendations for 2022-2023
.
This guideline is applicable to professionals engaged in influenza prevention and control, such as disease control institutions, medical institutions, maternal and child health care institutions, and vaccination units
.
healthy child infant disease care